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Over a 104-day feedlot period, Revalor-S, Compudose 100 aud Synovex-S implanted 
Droughtmaster-Santa Gertrudis-Brahmau composite steers achieved a higher level of auimal 
performauce thau non-implanted (Control) or Component T-S implanted steers when fed for 
the Shortfed Japauese Export Market. For most measured parameters Revalor-S, Compudose 
100 and Synovex-S implanted steers were similar. Steers implanted with Component T-S did 
not perform any better thau non-implauted (Control) steers. The steers implanted with Ralgro 
were generally intermediate in performauce. 
Revalor-S, Compudose 100 and Synovex-S implanted steers recorded significantly greater 
(P<0.05) finishing period (Day 22-104) dry matter intakes, Day 70 and exit liveweights, 
average daily gains (ADG) to Day 70 and to exit aud carcase weights aud significautly lower 
(P<0.05) overall feed conversion ratios thau Control aud Component T-S implauted steers. 
The Ralgro implauted steers were never uniquely superior in measured parameters compared 
with the Control aud Component T-S implanted steers. Component T-S steers had less 
subcutaneous fat at the PS site than the other ctreatments. 
Preputial disorders as a result of hormonal growth promotant (HGP) implantation were 
observed across all treatments except the Control. A significantly lower (P<0.05) proportion 
of preputial disorders were recorded in Control (0%) and Component T-S steers (5%) 
compared with 30% for Compudose 100 aud Synovex-S, 39% for Ralgro aud 43% for 
Revalor-S. Preputial disorders were first observed at Day 6. Veterinary treatment was 
required for 2 steers from each of the Compudose 100, Synovex-S aud Revalor-S treatments. 
Steers with a Bull power assessment sheath score of >4 had significautly (P<0.01) less (17%) 
preputial disorders thau steers with a sheath score of :s;4 ( 40% ). 
A number of relationships between steer characteristics aud performauce and carcase 
attributes were investigated. Steers with hip heights at induction of 1400-1425 mm and 
>1425 mm had significantly heavier (P<0.001) carcases (336 and 337 kg respectively) thau 
steers with induction hip heights of <1400 mm (321 kg). Steers with au Australiau body 
condition score (AUS BCS) of :s;5 or 6 at induction had significautly less (P<0.01) 
subcutaneous fat depth at the PS site (14.l and 15.3 mm respectively) thau steers of AUS BCS 
7 (19.0 mm). A similar result was achieved when the steers were scored using a United States 
body condition scoring system (US BCS). Steers with a US BCS of :s;5 had a significautly 
greater (P<0.05) ADG over the complete study period (1.67 kg/hd/day) than steers of US BCS 
6 or 7 (1.52 and 1.42 kg/hd/day respectively). 
There was a significaut interaction (P<0.05) between HGP treatment and induction US BCS 
for carcase PS fat depth. Induction US BCS did not influence carcase PS fat depth of Ralgro, 
Synovex-S, Revalor-S aud Component T-S treated carcases, whereas au induction US BCS of 
7 resulted in significantly more (P<0.05) PS fat depth in the Control aud Compudose 100 
treated carcases compared with lower US body condition scores. 
The steers used in the study were from 2 origins. Steers from the 2 origins differed in a 
number of body characteristics and also in performance in the feedlot. 
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Introduction 
Animal pharmaceutical companies in Australia continue to release new hormonal growth 
promotants (HGP's). These products are separable into eight groups based on their active 
compounds. Some products are recommended for grazing animals only, however, the 
majority of products are generally used in feedlot cattle of both sexes. 
The various HGP's are used for different purposes in the feedlot, eg. to improve growth rate 
or carcase specifications through modification of body composition. 
Due to the number of HGP's now available, the selection of the most suitable HGP for the 
Brigalow Research Station Feedlot Research Facility for use in steers destined for the 
Shortfed Export market was constrained by a lack of comparative data. The opportunity was 
taken in the Brigalow Research Station feedlot to screen for this market over 100 days a 
number ofHGP's selected as representative of the 5 implant groups that are generally specific 
to feedlot use. 
Method 
The study was conducted at the Queensland Department of Primary Industries' Brigalow 
Research Station, Theodore, Queensland (240° SO'S, 149° 48'E) between March 2000 and 
July 2000. The Feedlot Research Facility is a Queensland Government licensed Class 2 
feedlot and AUS-MEAT accredited (No. 390). This approved study was conducted under the 
guidelines of the Tropical Beef Centre Animal Experimentation Ethics Committee. 
Design 
In March 2000, 144 Droughtmaster - Santa Gertrudis - Brahman composite steers of mean 
unfasted liveweight of 495 kg were randomly allocated on liveweight within origin (Theodore 
or Alpha) to one of 12 pens. There were 12 steers per feedlot pen at a stocking rate density of 
1 steer I 12.5 m2 with four steers from Theodore and eight steers from Alpha. Six treatments 
were allocated to the 12 pens as a randomised complete block design with 2 replicates of each 
treatment. The Theodore cattle arrived at Brigalow in February 1999 and the Alpha cattle in 
May 1999. All steers were in common grazing for five months prior to induction. 
Treatments 
The six HGP treatments were:-
Tl- Control, nil HGP 
T2- Ralgro ® (36mg Zeranol), Coopers Animal Health 
T3- Compudose 100® (20mg Oestradiol), Elanco Animal Health 
T4- Synovex - s® (20mg Oestradiol benzoate and 200mg Progesterone), Fort Dodge. 
TS- Revalor - s® (28mg Oestradiol benzoate and 140mg Trenbolone acetate), Intervet. 
T6- Component T - s® (140mg Trenbolone acetate), Elanco Animal Health. 
Experimental procedure 
At induction on March 29, 2000, all steers were weighed, assessed for various anatomical 
characteristics, vaccinated for botulism (Singvac®), treated with Bayticol Pour-On® and the 
relevant steers implanted with their treatment HGP. The anatomical characteristics recorded 
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were hip height, an Australian Body Condition Score (AUS BCS) with a 9 point scale from 1 
- Emaciated to 9- Overfat (Holroyd, 1978), a US Body Condition Score (US BCS) also with 
a 9 point scale from 1 - Thin condition to 9 - Fat Condition (Herd and Sprott, 1996) and 
Prepuce/Sheath scores based on the 5 point Bullpower Assessment System of 2 -
unacceptable, to 9 - excessively clean (Holroyd et al., 2000; Appendix A). As described in 
the Bullpower Assessment System, the prepuce consists of two parts; the external hair 
covered appendage or sheath and the inner part or prepuce proper. 
Following induction, all steers were fed introductory rations for the first 21 days. The 
introductory period comprised a 'step-up' program of three energy levels to gradually 
increase the grain content. 
The finishing ration was fed from Day 22 onwards and was composed of 69% dry rolled grain 
(50% wheat: 50% sorghum blend), 2.5% molasses, 1% cottonseed meal, 4.5% supplement, 
2.5% blended oil mix, 10% whole cottonseed, 2% hay and 8.5% sorghum silage for days 22 
to 60. From days 61 to 104, the ration was composed of 72.5% dry rolled sorghum, 2% 
molasses, 4.5% supplement, 2% blended oil Jllix, 9% whole cottonseed, 2% hay and 8% 
sorghum silage. The ration composition was changed when wheat supplies were exhausted 
and the cost of alternative sources of wheat were prohibitive. 
Each treatment pen was fed twice per day at approximately 7.00am - 8.00am (AM) and 
3.00pm - 4.00pm (PM) with approximately 35% of daily feed offered in the AM and 65% in 
the PM. The total allocation of daily feed on a pen basis (PM and following AM) was 
determined prior to feeding in the PM (Clean Bunk at Midday program (Lawrence, 1998)). 
Samples of rations were collected from each pen twice per day at feeding. Residues of spoilt 
rations were collected whenever such rations were discarded. Health and welfare inspections 
of the steers were made daily, including inspection for prepuce related problems assessed as 
animals were encouraged to move from a stationary position. A true preputial prolapse occurs 
when a male beast is unable to retract the prepuce into the sheath. The incidence of preputial 
tipping (prepuce exposed to approximately 50 mm in length beneath the preputial opening) 
and the incidence of swollen exposed prepuces were recorded as preputial disorders. Steers 
with significant preputial prolapses were inspected by a veterinarian and treated as required. 
Unfasted liveweights were recorded from approximately 11. OOam - 1. OOpm on Days 21 (end 
of the introductory period), 70 (estimated completion ofHGP payout for most of the HGP's) 
and 104. On day 104, the steers were again assessed for a number of anatomical 
characteristics, excluding the Prepuce/Sheath score. 
During the course of the study, 9 steers were removed for various reasons. The data analysed 
in the study were based on the remaining 135 steers. 
A set procedure at turnoff for slaughter at the end of the feedlot period was carried out. 
Following liveweight recording on Day 104, all steers were returned to their treatment pens 
and fed as normal in the PM of that day. From 8.00am of the following day (Day 105), the 
steers were transported for 2 hours to a Biloela abattoir. Upon arrival the steers were held 
overnight with access to water. During the following morning, all steers were slaughtered and 
AUS-MEAT feedback carcase data recorded. 
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Nutritional analysis 
Rations during the finishing period were suitable for finishing steers for the desired market. A 
nutritional analysis of the finishing rations, on a dry matter basis, is presented in Table 1. 
Table 1. Nutritional analysis for finishing rations on a dry matter basis. 
DM Ash Fat ME Protein Crude Ca p 
(%) (%) (%) (Mj/kg} (%} Fibre (%) (%) (%) 
Sorghum-wheat ration 86.5 5.8 7.9 13.6 16.6 7.0 0.93 0.45 
Sorghum ration 84.5 5.0 9.3 13.8 15. I 8.4 0.80 0.36 
Statistical analysis 
Average daily Iiveweight gains (kg/d) were 6~Iculated for all periods (introductory period, end 
of introductory period to end of pay-out, entry to end of pay-out, end of pay-out to exit, entry 
to exit, end of introductory period to exit). Average feed intake per animal per day (kg/hd/d), 
on a dry matter basis and feed conversion ratios (kg fed I kg weight gain) were calculated for 
the same periods as average daily liveweight gains. 
Liveweight at each weighing time, average daily gain, feed intake and feed conversion ratios 
over each of the 6 periods, hip height at feedlot entry and exit and change in hip height, hot 
standard carcase weight, dressing percentage and subcutaneous fat depth at the PS site were 
analysed by analysis of variance. Pen variation was used to test the effects of the HGP 
treatments while animal variation was used to test differences in steer origin and its 
interaction with HGP treatments. 
Body condition scores (both AUS BCS and US BCS) at feedlot entry and exit and the change 
over the study were analysed as both continuous and discrete data. Treating BCS as 
continuous data, analysis of variance was used to test HGP treatment effects as described 
above. Chi-squared analysis for contingency tables was used to analyse BCS when considered 
as discrete data. Due to low cell counts for individual scores, the following categories were 
considered: three categories for BCS (both AUS and US) at entry to the feedlot (score s5, 6 or 
7); two categories for BCS at feedlot exit (score s7 or score of S); and two categories for 
change in BCS (s 1 unit change or> 1 unit change). 
To investigate the relationships of hip height and BCS (both AUS and US) at feedlot entry 
with carcase weight, dressing percentage, PS fat and average daily gain over the 70-day pay-
out period and over the 104-day feedlot period, factors were derived from hip height and BCS 
as follows: hip height with 3 levels(< 1400 mm, 1400-1425 mm,> 1425 mm) and BCS (both 
AUS and US) with 3 levels (score s5, 6, 7). The data were then analysed with the animal 
variation partitioned into one of these 3 factors. As the data were unbalanced, they were 
modelled by residual maximum likelihood (REML). 
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If a steer is likely to suffer from preputial disorders (preputial tipping or swollen prepuce) 
resulting from treatment with a HGP, it was most likely to occur in the period immediately 
following implantation and entry into the feedlot. Also, it was expected that a steer observed 
to have preputial tipping or a swollen prepuce would show symptoms for a number of days 
rather than a one-off occurrence which is more likely to be an observation error. Therefore, 
incidence of preputial disorders was defined as two or more consecutive observations of 
preputial tipping or swollen prepuce in the first 14 days following feedlot entry. Log-linear 
modelling was used to test independence among incidence of preputial disorders, HGP 
treatments and sheath score which was categorised as unacceptable (score ~ 4) or acceptable 
(score> 4). · 
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Results and discussion 
Seasonal conditions 
Rainfall was above average in April 2000 (84.2 over 9 wet days, compared to long term 
average of 51.9 mm) and below average in May (23.5 mm over 9 wet days, compared to long 
term average of 55.9 mm) and June 2000 (28.8 mm over 4 wet days, compared to long term 
average of 56.9 mm). Rainfall in April resulted in ongoing wet pen conditions and the 
continuation of rainfall over a number of days in May resulted in the pens remaining in a less 
than desirable condition. Temperatures were considered mild over the experimental period. 
Steer characterisation 
Most of the treatments had a similar distribution of sheath scores except Compudose 100 
which recorded the lowest proportion of Score 4 and highest proportion of Score 6 steers 
(Table 2). The major difference in score distribution between origin of steers was that 
Theodore had more Score 2 and 4 steers wl\ile Alpha had more Score 8 steers. 
Table 2. Distribution of sheath scores (%) at induction. 
No. Sheath Score 1 
steers 2 4 6 8 9 
Treatment 
Control 23 5 26 30 30 9 
Ralgro 23 9 35 26 30 -
Compudose 100 23 4 9 70 13 4 
Synovex S 23 4 30 40 22 4 
Revalor-S 21 5 29 57 9 -
Component T-S 22 9 23 50 18 -
Origin 
Theodore 48 12 33 43 12 -
Alpha 87 3 21 45 26 5 
I 
-Sheath scores (Holroyd et al., 2000) refer to Appendix A where. 
9 Excessively clean 
8 Optimum: sheath hangs at a 45° angle and is well controlled. 
6 Acceptable: sheath hangs at a 45° angle but has slightly more leather than desired. 
4 Marginal: excessive loose leather in navel area; slightly pendulous sheath that opens at a 90° angle to 
the body. 
2 Unacceptable: extremely pendulous sheath at 90° angle or extremely large preputial opening. 
The range in individual steer hip heights at induction was 1275 to 1525 mm and at exit was 
1325 to 1575 mm. Hip heights at induction and exit and the increase in hip heights over the 
feeding period did not differ (P>0.10) among HOP treatments (Table 3). The steers from 
Theodore had significantly lower (P<0.001) hip heights at both induction and exit but 
recorded a significantly greater (P<0.001) increase in hip heights than the steers from Alpha. 
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Table3. Hip heights of steers from two origins given different growth promotants. Means within 
columns followed by the same letter are not significantly different at P = 0.05. 
Hip height Change in hip height 
{mm) (mm) 
Induction Exit 
Treatment n.s. n.s. n.s. 
Control 1414 1447 33.4 
Ralgro 1411 1455 43.3 
Compudose 100 1406 1454 47.4 
Synovex S 1423 1470 46.5 
Revalor-S 1416 1464 48.5 
Component T-S 1419 1458 39.l 
l.s.d. (P = 0.05) 43 47 12. 1 
Origin *** *** *** 
Theodore 1373 b 1427 b 53.l' 
Alpha 1436' . 1474' 38.0 b 
l.s.d. (P = 0.05) 14 15 8.1 
n.s. - not s1gmficant (P>0.10); *** P<0.001 
At induction there was no difference among treatments in body condition score using either 
of the two scoring systems (Table 4). At exit, steers from the Ralgro, Compudose 100 and 
Revalor-S treatments had significantly greater (P<0.05) AUS BCS's than the Control and 
Component T-S treatment steers. Similar but weaker differences among treatments were 
observed in scores assessed by the US system at exit. There was no difference in change in 
body condition among treatments using either system. 
At feedlot exit there was a significantly greater (P<0.05) proportion of Ralgro and a lesser 
proportion of Component T-S steers with AUS BCS of 8 compared with the other treatments. 
A similar result was observed for the US BCS at exit 
Steers from both origins were similar (P>O. l 0) in body condition at induction when assessed 
using either system. At exit, using either system, the Theodore origin steers recorded 
significantly greater (P<0.001) scores and a significantly greater (P<0.05) change in body 
condition throughout the study than the Alpha steers. 
Overall, both body condition scoring systems were generally similar as both indicated the 
same trends due to treatment and origin of steers. 
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Table 4. Body condition score (BCS) and change in BCS of steers from two origins and given 
different growth promotants. Means within columns followed by the same letter are not 
significantly different at P = 0.05. 
Australian BCS1 
Induction Exit Change Induction 
Treatment n.s. * n.s. 
Control 6.0 7.2 b 1.2 
Ralgro 6.1 7.6 ' 1.5 
Compudose 100 6.1 7.5' 1.4 
Synovex-S 6.1 7.3 'b 1.3 
Revalor-S 6.1 7.5' 1.4 
Component T-S 6.0 7.1 b 1.2 
l.s.d. (P = 0.05) 0.3 0.3 0.4 
Origin n.s. *** ** 
Theodore 6.0 7.6' 1.5 ' 
Alpha 6.0 7.3 b 1.2 b 
l.s.d. (P = 0.05) 0.2 0.2 0.2 
' Nme pomt sconng system from 1 (emaciated) to 9 (overfat). 
2 Nine-point scoring system from 1 (thin condition) to 9 (fat condition). 
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Feed intakes on a dry matter basis are presented in Table 5. The period from Day 1 to 70 
approximated the payout period for all implants except Compudose 100. For this reason, 
periods prior to and beyond the approximate payout date have been included. 
Over the finishing period (Day 22 to 104), the Compudose 100, Synovex S and Revalor-S 
treatments were similar and recorded significantly greater (P<0.05) intakes than the Control 
and Component T-S treatments. The Compudose 100 treatment also recorded significantly 
greater (P<0.05) intakes than Ralgro over the same period. Intake for all other periods did 
not differ significantly among treatments although there was a trend across all periods for 
Compudose 100 and Synovex-S treatments to have the greatest intakes, Control and 
Component T-S to have the least while Ralgro and Revalor-S were often intermediate. 
It is interesting to note that the greatest mean intakes were recorded in the post HGP payout 
period for all treatments. However, these greater intakes were most likely due to the change 
of grain in the ration from a sorghum-wheat blend to sorghum alone which occurred at Day 
60 when wheat supplies became limiting. 
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Table 5. Dry matter basis feed intakes (kg/day) for steers from different hormonal growth 
promotant treatments. Means within columns followed by the same Jetter are not 
significantly different at P = 0.05. 
Treatment Introductory Finishing Overall Induction to 
period Period end of payout1 
<Dav 1-21\ (Dav 22 - 104) (Dav 1- 104l <Dav 1-70) 
n.s. * P=0.079 D.S. 
Control 8.69 I 1.79 ' 11.17 10.37 
Ralgro 9.49 12.17 bo I 1.63 10.87 
Compudose 100 10.92 12.88 • 12.48 I 1.86 
Synovex-S 10.09 12.78 ob 12.23 I 1.64 
Revalor-S 8.71 12.61 ob I 1.82 11.11 
Component T-S 9.51 I 1.67 ' I 1.23 10.58 
Ls.d. (P = 0.05) 3.33 0.70 0.97 1.24 
' Day 70 considered end of payout for Ralgro, Synovex-S, Revalor-S and Component T-S 
n.s. - not significant (P>O. JO);* P<0.05. 
Liveweight performance 











There were no differences in liveweight ~ong any of the treatments at induction or at the 
end of the introductory period (Table 6). At the end of payout for most of the HGP's (Day 
70), steers in the Compudose 100, Synovex-S and Revalor-S treatments were similar in 
liveweight and were all significantly heavier (P<0.05) than steers in the Control and 
Component T-S treatments while steers in the Ralgro treatment were intermediate (Table 6). 
At the same time, the Revalor S treatment was also significantly heavier (P<0.05) than the 
Ralgro treatment. At exit, there were no differences in liveweight among Ralgro, Compudose 
100, Synovex-S and Revalor-S and all these except Ralgro were significantly heavier 
(P<0.05) than the Control and Component T-S treatments. 
At induction, the steers from Alpha were significantly heavier (P<0.01) than those from 
Theodore (Table 6). This difference reduced so that by the end of payout (Day 70) and at exit 
there was no differences in liveweight between place of origin of the steers. 
Table 6. Liveweights (kg) of steers from two origins and given different hormonal growth 
promotants. Means within columns followed by the same letter are not significantly 
different at P = 0.05. 
Induction End of End of payout1 
introductory period 
(Dav 21) (Dav 70) 
Treatment n.s. n.s. * 
Control 494.7 505.5 584.2' 
Ralgro 497.2 510.3 597.4 bo 
Compudose 100 491.4 518.9 61 J.7 ob 
Synovex-S 497.5 521.3 610.6 •b 
Revalor-S 498.8 516.6 62 I. 7 ° 
Component T-S 497.9 508.3 588.3 ' 
1.s.d. (P=0.05) 9.2 28.5 21.1 
Origin ** P=0.073 n.s. 
Theodore 475.8 b 506.6 602.0 
Alpha 506.5 • 516.9 602.5 
1.s.d. (P=0.05) 9.1 11.3 13.6 
' Day 70 considered end of payout for Ralgro, Synovex-S, Revalor-S and Component T-S. 
















There were no significant differences in ADG among the treatments over either the 
introductory period or finishing period, although similar trends in each period resulted in 
differences among treatments over the entire study (Table 7). Over the entire study period 
and over the 70-day payout period, the Revalor-S, Compudose 100 and Synovex-S treatments 
recorded similar ADG's which were significantly greater (P<0.05) than for the Control and 
Component T-S treatments while Ralgro was intermediate. Revalor-S also resulted in 
significantly greater (both P<0.05) ADG's than Ralgro over both these periods while over the 
payout period, Compudose 100 had significantly greater (P<0.05) ADG's than Ralgro. 
Differences in ADG between origin of steers were recorded for each period, with the weakest 
(P=0.060) evidence over the finishing period (Table 7). The Theodore steers recorded greater 
ADG's than the Alpha steers for each period except from the end of payout to exit in which 
the Alpha steers recorded significantly greater (P<0.001) ADG's than the Theodore steers. 
Table 7. Average daily gains (kg/had/day) of steers from two origins and given different hormonal 
growth promotants. Means within columns followed by the same letter are not 
significantly different at P = 0.05. 
_/ 
Introductory Finishing Overall Introduction to 
period Period end of payout' 
(Day 1-21) (Dav 22 -104) (Dav 1-104) (Dav 1-70) 
Treatment n.s. n.s. • • 
Control 0.51 1.40 1.27' 1.28' 
Ralgro 0.62 1.62 1.47"' 1.43 ho 
Compudose I 00 1.31 1.72 1.70 •h 1.72' 
Synovex-S 1.14 1.67 1.62" 1.62 •h 
Revalor-S 0.85 1.70 1.72' 1.76' 
Component T-S 0.49 1.39 1.30' 1.29' 
l.s.d. (P=0.05) 1.04 0.35 0.24 0.26 
Origin ••• P=0.060 *** *** 
Theodore 1.47' 1.69 1.65' 1.80' 
Alpha 0.50 b 1.53 1.45 b 1.37 b 
1.s.d. (P=0.05) 0.31 0.17 0.10 0.13 
' Day 70 considered end of payout for Ralgro, Synovex-S, Revalor-S and Component T-S. 
n.s. - not significant (P>0.10); * P<0.05; *** P<0.001. 
Feed conversion ratios 
End of payout 
to exit 













Feed conversion ratios (FCR) for various periods of the study are shown in Table 8. There 
were no significant differences in FCR among treatments for either the introductory period 
(due primarily to large variation in liveweight gains over this period; Table 7) or the finishing 
period (Table 8). For the overall period of the study, Revalor-S, Compudose 100 and 
Synovex-S had a similar FCR which was significantly lower (P<0.05) than for the Control 
and Component T-S treatments while the FCR for Ralgro was intermediate. Over the 70-day 
payout period, differences were similar to the overall period except Revalor-S recorded a 











Feed conversion ratios (kg feed (DM basis) I kg weight gain) of steers from different 
hormonal growth promotant treatments. Means within columns followed by the same 
letter are not significantly different at P = 0.05. 
Introductory Finishing Overall Introduction to End of payout 
period period end of payout1 to exit 
a 1-21 a 22-104 a 1-104 a 1-70 Da 71-104 
n.s. n.s. * * n.s. 
25.32 8.14 8.83. 8.11 ° 10.55 
22.71 7.21 7.92 ob 7.64 ob 8.47 
8.66 7.17 7.36"' 6.91 bo 8.33 
8.89 7.35 7.56 bo 7.21 b 8.29 
13.19 6.49 6.88' 6.33' 8.19 
36.34 7.75 8.63. 8.19' 9.52 
45.78 1.27 0.97 0.87 2.67 
Day 70 considered end of payout for Ralgro, Synovex-S, Revalor-S and Component T-S. 
n.s. - not significant (P>0.10); * P<0.05. / 
Preputial disorders 
Preputial disorders were first observed at Day 6. The incidence of preputial disorders is 
shown in Table 9 where incidence was defined as 2:2 consecutive observations of preputial 










Incidence of preputial disorders categorised by hormonal growth promotant treatment 
and sheath score (:S:4 or >4). Overall percentage incidence is shown in parentheses. 
Incidence of preputial disorders 
(No. with disorders/No. in sheath score category} 
Sheath score Total incidence 
:S:4 >4 
(Unacceptable) (Acceptable) 
017 0/16 0/23 (0) 
6/10 3/13 9/23 (39) 
2/3 5/20 7/23 (30) 
4/8 3/15 7/23 (30) 
4/7 5/14 9/21 (43) 
1/7 0/15 1/22 (5) 
17/42 (40) 16/93 (17) 33/135 (24) 
There was no interaction between HGP treatment and sheath score (acceptable (score >4) or 
unacceptable (score :o;4)). A significantly lower (P<0.05) proportion of steers from the 
Control (0%) and Component T-S (5%) treatments were observed with preputial disorders 
compared with the other treatments (30%, 30%, 39% and 43% for Compudose 100, Synovex-
S, Ralgro and Revalor-S respectively). Also, a significantly greater (P<0.01) proportion of 
steers with a sheath score of :o;4 had preputial disorders compared with steers with sheath 
scores >4 ( 40% versus 17% respectively). The results highlight that for similar genotypes 
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consideration could be given to selecting steers on sheath score to avoid preputial disorders 
associated with the use ofHGP's. 
Some steers required veterinary treatment for preputial prolapses with 2 from each of the 
Compudose 100, Synovex-S and Revalor-S treatments. Ralgro implanted steers, while 
recording a 39% incidence of preputial disorders, did not require veterinary treatment for 
prolapsed prepuces. 
Carcase attributes 
Apart from 2 steers (1.5%) all graded for the Shortfed Japanese Export Market. Carcase 
attributes recorded at slaughter are shown in Table 10. There was no significant difference in 
carcase weight among Compudose 100, Synovex-S and Revalor-S treatments. However, 
Compudose 100, Synovex-S and Revalor-S carcases were significantly heavier (P<0.05) than 
Control and Component T-S treatment carcases while Revalor-S carcases were significantly 
heavier (P<0.05) than Ralgro carcases. 
Comparatively, carcase weight was 3.4% (Jlalgro), 6.6% (Compudose 100), 6.9% (Synovex-
S), 9.8% (Revalor-S) and 1.2% (Component T-S) greater compared with the carcase weight 
of the Control treatment. The response reported for Compudose 100 and Synovex-S is 
similar to other studies, the response to Revalor-S is greater than normally reported and the 
responses for both Ralgro and Compudose T-S were lower than normally reported. 
Overall, dressing percentage was 50.8%, a reflection of the time of liveweight recording at 
exit resulting in conditions of significant rumen fill. There were no significant differences in 
dressing percentage among treatments. 
There was weak evidence (P=0.066) of differences in subcutaneous fat depth at the P8 site 
among treatments with carcases from the Component T-S steers having less subcutaneous fat 
thickness than the other treatments. Component T-S is a strongly adrenogenic compound and 
was included in the study for the purpose of monitoring its influence on carcase fatness. 
Component T-S is an implant that is nonnally recommended for use in combination with an 
oestrogenic implant. 
There were no significant differences in carcase weight or dressing percentage between origin 
of steers, however the Theodore steers had significantly greater (P<0.01) subcutaneous fat 
depth at the PS site than the Alpha steers. 
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Table 10. Carcase attributes of steers from two origins and given different hormonal growth 
promotants. Means within columns followed by the same letter are not significantly 
different at P = 0.05. 
Hot standard carcase weight PS fat depth 
(kg) (mm) 
Treatment * P=0.066 
Control 317.3' 16.2 
Ralgro 328.2 bo 15.5 
Compudose I 00 338.2 •b 17.9 
Synovex-S 339.3 •b 15.2 
Revalor-S 348.3 ' 16.0 
Component T-S 321.2' 13.4 
l.s.d. (P=0.05) 15.1 2.6 
Origin ~-;,S· ** 
Theodore 330.0 17.2 ' 
Alpha 333.1 15.0 b 
l.s.d. (P=0.05) 7.5 1.7 
n.s. - not sigmficant (P>0.10); * P<0.05; ** P<0.01. 
The AUS-MEAT chiller assessment data from this study were not analysed due insufficient 
variability as the majority of carcases recorded nil marbling, lB in meat colour and 'O' or '1' 
in fat colour. 
Relationships between steer characteristics and liveweight gain and carcase attributes. 
Steers with hip heights of 1400 - 1425 mm and >1425 mm at feedlot induction had 
significantly heavier (P<0.001) carcases (336 and 337 kg respectively) than steers with 
induction hip heights <1400 mm (321 kg). There were no significant relationships between 
hip height and dressing percentage, subcutaneous fat depth at the P8 site, or ADG over the 
70-day payout period or the overall period. 
There were no significant relationships between the A US BCS at induction and carcase 
weight, dressing percentage and ADG to the end of payout or over the overall period. Steers 
with an AUS BCS of :£5 or 6 had significantly less (P<0.01) P8 fat depth (14.l and 15.3 mm 
respectively) than steers of AUS BCS 7 (19.0 mm). 
Similar to the AUS BCS, there were no significant relationships between US BCS at 
induction and carcase weight or dressing percentage. In respect to growth rate, steers of US 
BCS :£5 recorded a significantly greater (P<0.05) ADG (1.75 kg/hd/day) to the end of payout 
(70 days) than steers of US BCS 6 or 7 (1.51 and 1.43 kg/hd/day respectively). Similarly, for 
the overall period, steers of US BCS :£5 had a significantly greater (P<0.05) ADG (1.67 
kg/hd/day) than steers of US BCS 6 or 7 (1.52 and 1.42 kg/hd/day respectively). 
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There was a significant interaction (P<0.05) between HGP treatment and induction US BCS 
for carcase PS fat depth but some cell numbers are quite low (Table 11 ). Induction US BCS 
did not influence carcase PS fat depth of Ralgro, Synovex-S, Revalor-S and Component T-S 
treated carcases, whereas an induction US BCS of 7 resulted in significantly more (P<0.05) 
PS fat depth in the Control and Compudose 100 treated carcases compared with lower US 
BCS's. 
Table 11. Carcase PS fat depth means across induction US BCS categories and hormonal growth 
promotant treatments. Cell numbers are given in parentheses. 
Induction BCS categories 
Treatment '.>5 6 7 
Control 14.00 (3) 15.20 (15) 20.60 (5) 
Ralgro 13.00 (3) 15.46 (13) 16.57 (7) 
Compudose 100 16.50 (4) 16.00 (15) 27.00 (4) 
Synovex-S 17.50 (6) 
.-./ 
13.92 (12) 15.60 (5) 
Revalor-S 10.00 (I) 16.07 (15) 17.20 (5) 
Component T-S 7.00 (I) 13.65 (20) 16.00 (I) 
Implications 
Steers implanted with Revalor-S, in particular, and steers implanted with Compudose 100 or 
Synovex-S HGP's out-performed and were more suitable to the Shortfed Market than non-
implanted or Component T-S implanted steers. Steers implanted with Ralgro were generally 
similar to the Control or Component T-S steers or intermediate in performance to the other 
implants. 
Consideration of genotype and sheath score should be given in the selection of steers for 
implantation with HGP's. For the genotype considered in this study, implantation with 
HGP's, except Component T-S, resulted in a significant number ofpreputial disorders. 
For the Brigalow Research Station Feedlot, Revalor-S, Compudose 100 and Synovex-S are 
suitable for implantation in similar steers intended for the Shortfed Export Market. However, 
consideration of sheath score and the incidence of preputial disorders would be necessary. 
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